(PDF) P2.01-52 Identification of Leptomeningeal

P2.01-52 Identification of Leptomeningeal Metastasis-Specific Exosomal miRNA Signatures in Cerebrospinal Fluids of NSCLC Patients

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1106

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Clinical Outcome of Cerebrospinal Fluid Shunts in Patients With Leptomeningeal Carcinomatosis

World Journal of Surgical Oncology

English

Whole Brain Radiation Therapy Does Not Improve the Overall Survival of EGFR-mutant NSCLC Patients With Leptomeningeal Metastasis

Radiation Oncology

Nuclear Medicine

English

MA16.10 Clinical Utility of Cerebrospinal Fluid Cell-Free DNA for Clarifying Genetic Features of Leptomeningeal Metastases in ALK Rearrangement NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-95 Assesment the Fitness for Chemotherapy of NSCLC Patients Using 6MWT

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-55 Unique Genetic Profiles From Cerebrospinal Fluid Could Predict Survival of EGFR-Mutant NSCLC With Leptomeningeal Metastases

Journal of Thoracic Oncology

Respiratory Medicine

English

Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis

Clinical Breast Cancer

Cancer Research

English

Profiling of Metalloprotease Activities in Cerebrospinal Fluids of Patients With Neoplastic Meningitis

Fluids and Barriers of the CNS

Molecular Neuroscience

Developmental Neuroscience

English

P2.03-18 X-Inactivation Specific Transcript (XIST)-Mediated miRNA Sequestration in NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Identification of Biomarkers for Amyotrophic Lateral Sclerosis by Comprehensive Analysis of Exosomal mRNAs in Human Cerebrospinal Fluid

BMC Medical Genomics

English